MeiraGTx Holdings PLC

MGTX Healthcare Biotechnology

MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.

9.28 0.61 −6.17%
Market cap
$949.9M
P/E
12.2×
Fwd P/E
−5.6×
Dividend yield
—
F-score
5/9
Altman Z
−4.39
Beneish M
−3.01
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(611.42%) (368.19%) 963.07% 72.22%
Piotroski F-Score
4 5 6 6
ROA
(69.00%) (44.42%) (51.44%) 26.54%
ROIC
0.00% 0.00% 0.00% 66.60%
Return on Tangible Assets
1,520.40% (152.94%) (532.23%) 30.31%
Average Days of Receivables
157.23 82.00 82.19 40.64
Free Cash Flow per Share
(1.49) (0.62) 0.05 0.11
Free Cash Flow
(120.50) (50.06) 4.28 10.12
Capital Expenditures
(4.24) (3.70) (3.99) (3.57)
Other line items
Cash ROIC
849.50% (45.53%) 6.78% 2.21%
Accounts Receivable Turnover
2.71 5.82 6.96 15.57
Accounts Payable Turnover
0.63 0.29 0.20 0.44
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
486.06 758.64 1,659.89 522.49
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 (0.03)
Research and Development Expense of Revenue
447.87% 159.25% 161.52% 38.53%
Selling, General and Administrative Expense of Revenue
191.06% 64.99% 65.78% 13.12%
Share Based Compensation of Revenue
82.51% 27.16% 26.17% 4.78%
Interest Coverage
(13.06) (8.69) (8.76) 14.75
Operating CF/Net income
0.69 0.41 (0.07) 0.17
Depreciation/Fixed assets
0.13 0.13 0.13 0.13
Capex/Depreciation
(0.31) (0.27) (0.29) (0.26)
Revenue per Share
0.34 1.01 0.98 4.35
Operating CF per Share
(1.44) (0.58) 0.10 0.15
Capex per Share
(0.05) (0.05) (0.05) (0.04)
Capex to Sales
0.15 0.05 0.05 0.01

Fold the line items

Columns are period end dates